Axxion S.A.’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$839K Hold
1,605
– – 0.06% 172
2026
Q2
$797K Buy
+1,605
New +$711K 0.06% 174

Other funds holding VRTX

Axxion S.A.'s VRTX Position: Q3 2026 in Review

Axxion S.A. held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 1,605 shares worth $839K. The position accounts for 0.06% of the portfolio, ranked #172.

Axxion S.A. first reported a position in VRTX in Q2 2026 and has held it in 2 quarters since. 1,786 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Axxion S.A. held 1,605 shares of Vertex Pharmaceuticals worth $839K as of Q3 2026.
  • Axxion S.A. left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
  • Vertex Pharmaceuticals made up 0.06% of Axxion S.A.'s portfolio in Q3 2026, its #172 holding.
  • Axxion S.A. first reported a position in Vertex Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 1,786 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Axxion S.A.'s 13F filing for Q3 2026, filed 22 Oct 2026.